مستخدم:MohammedNawaiseh.md/ملعب
المقالة الإنجليزية | طول المقالة الإنجليزية | الأهمية | الجودة | طول المقالة العربية |
---|---|---|---|---|
Acute tubular necrosis | 753 | Low | Start | 261 |
Acute uric acid nephropathy | 408 | Mid | Start | 419 |
Adipsia | 1542 | Low | Stub | Missing |
Blood urea nitrogen | 514 | Mid | Start | 238 |
Branchio-oto-renal syndrome | 839 | Low | Start | Missing |
Brewer infarcts | 41 | Low | Stub | Missing |
Richard Bright | 1310 | Low | Start | 390 |
BUN-to-creatinine ratio | 1877 | Low | C | Missing |
Calciphylaxis | 1339 | Low | Start | Missing |
Cholesterol embolism | 1595 | Low | B | Missing |
Clearance | 1621 | Mid | C | 99 |
Clinical urine tests | 3052 | Low | Start | 218 |
Costovertebral angle tenderness | 291 | Low | Stub | Missing |
Cystatin C | 5002 | Low | B | Missing |
Diabetes insipidus | 2776 | Mid | B | 465 |
Dialysis disequilibrium syndrome | 472 | Mid | Start | Missing |
Diuresis | 1653 | Mid | Start | Missing |
DMSA scan | 266 | Low | Stub | Missing |
[[:en:European Renal Association ظô European Dialysis and Transplant Associati
on|]] |
712 | Low | Start | Missing |
Familial renal amyloidosis | 293 | Low | Stub | Missing |
Glomerular hyperfiltration | 79 | Low | Stub | ? |
Granulomatosis with polyangiitis | 2073 | Mid | B | 225 |
Haff disease | 584 | Low | Start | Missing |
Hemofiltration | 1065 | Mid | Start | 492 |
Hemolytic-uremic syndrome | 4404 | Mid | B | 321 |
HenochظôSch├╢nlein purpura | 2553 | Mid | GA | 499 |
Home hemodialysis | 4095 | Mid | B | Missing |
Hypermagnesemia | 1036 | Low | Start | Missing |
Hypomagnesemia | 2067 | Mid | B | Missing |
Hypomagnesemia with secondary hypocalcemia | 1410 | Low | Start | Missing |
Iminoglycinuria | 2526 | Low | B | Missing |
International Society of Nephrology | 478 | Low | Start | Missing |
Lloyd's sign | 75 | Low | Stub | Missing |
Loin pain hematuria syndrome | 1964 | Low | C | Missing |
Membranoproliferative glomerulonephritis | 946 | Low | Start | Missing |
Microangiopathic hemolytic anemia | 320 | Mid | Stub | [[┘┘é╪▒ ╪د┘╪»┘à ╪د┘╪د┘╪ص┘╪د┘┘è ╪ذ╪د╪╣╪ز┘╪د┘ ╪د┘╪ث┘ê╪╣┘è╪ر ╪د┘╪»┘é┘è┘é
╪ر|111]] |
Milligram per cent | 152 | Low | Stub | 141 |
Myeloma cast nephropathy | 114 | Low | Stub | Missing |
Nephrogenic systemic fibrosis | 1393 | Mid | Start | Missing |
Nephrotoxicity | 489 | Mid | Start | 200 |
Non-modulating essential hypertension | 91 | Low | Stub | Missing |
Normal anion gap acidosis | 362 | Low | Start | Missing |
Orellanine | 1070 | Low | Start | Missing |
Osmol gap | 1018 | Low | C | Missing |
Percutaneous nephrostomy | 131 | Low | Stub | Missing |
Peritoneal equilibration test | 222 | Mid | Stub | Missing |
Plasma renin activity | 849 | Mid | B | Missing |
Protein toxicity | 774 | Low | Start | Missing |
Pseudohypoaldosteronism | 614 | Low | Stub | Missing |
Pump leak model | 147 | Low | Stub | Missing |
Pyelonephritis | 2460 | Mid | B | 154 |
Reflux nephropathy | 386 | Mid | Start | Missing |
Renal Association | 231 | Low | Stub | Missing |
Renal clearance ratio | 90 | Low | Stub | Missing |
Renal colic | 417 | Mid | Start | 320 |
Renal ectopia | 122 | Mid | Stub | Missing |
Renal replacement therapy | 433 | Low | Stub | 299 |
Renal threshold | 165 | Low | Stub | Missing |
Renovascular hypertension | 810 | Low | Start | Missing |
Supernumerary kidney | 112 | Mid | Stub | Missing |
Tram track | 160 | Low | Stub | Missing |
Trans-tubular potassium gradient | 299 | Low | Stub | Missing |
UK National Kidney Federation | 194 | Low | Stub | Missing |
Uremic fetor | 138 | Low | Stub | Missing |
Urinary cast | 1135 | Mid | Start | Missing |
Uroscopy | 1353 | High | Start | Missing |
Vascular access steal syndrome | 821 | Mid | Start | Missing |
World Kidney Day | 139 | Low | Stub | 96 |
Erythropoiesis-stimulating agent | 3155 | Mid | C | Missing |
Darbepoetin alfa | 1046 | High | Start | Missing |
Erythropoietin | 2249 | Mid | B | 398 |
Medullipin | 167 | Low | Stub | Missing |
Renin | 2686 | Mid | B | 399 |
Urodilatin | 1240 | Mid | Start | Missing |
Arterial stiffness | 991 | Mid | Start | 146 |
Benign hypertension | 88 | Mid | Stub | Missing |
Critical limb ischemia | 462 | Mid | Start | Missing |
Exercise hypertension | 293 | Mid | Stub | Missing |
History of hypertension | 1573 | Mid | C | Missing |
Hypertensive crisis | 537 | Mid | Start | ? |
Hypertensive nephropathy | 288 | Mid | Stub | 150 |
Hypertensive urgency | 140 | Low | Stub | Missing |
Paroxysmal hypertension | 69 | Low | Stub | Missing |
Portal hypertension | 1357 | Mid | Start | 476 |
Portopulmonary hypertension | 2323 | Low | C | Missing |
Posterior reversible encephalopathy syndrome | 680 | Low | Start | Missing |
Pseudohyperaldosteronism | 236 | Low | Stub | Missing |
Pulmonary venoocclusive disease | 839 | Low | Start | Missing |
Renal sympathetic denervation | 1201 | Mid | C | Missing |
Salt and cardiovascular disease | 3547 | Low | Start | Missing |
Systolic Blood Pressure Intervention Trial | 386 | Low | Start | ? |
Systolic hypertension | 972 | High | C | 196 |
White coat hypertension | 1386 | Mid | Start | 218 |
Adaprolol | 216 | Low | Stub | Missing |
Afurolol | 199 | Low | Stub | 205 |
Alprenoxime | 337 | Low | Stub | Missing |
Ancarolol | 197 | Low | Stub | Missing |
Arnolol | 212 | Low | Stub | 181 |
Corynanthine | 805 | Low | Stub | Missing |
Hydrochlorothiazide | 1558 | Mid | C | 392 |
Methyldopa | 1122 | Low | Start | 321 |
Pargyline | 496 | Mid | Stub | Missing |
Pildralazine | 176 | Low | Stub | Missing |
Xibenolol | 163 | Low | Stub | Missing |
Xipranolol | 179 | Low | Stub | Missing |
Angiotensin II receptor antagonist | 2710 | Mid | C | 101 |
Discovery and development of angiotensin receptor blockers | 4760 | Low | B | Missing |
Irbesartan | 584 | Mid | Start | 281 |
Amoxapine | 3352 | Mid | Start | Missing |
Imipramine | 2102 | High | B | 374 |
Piperoxan | 396 | Low | Stub | Missing |
Yohimbine | 1496 | Low | C | Missing |
Mepiprazole | 846 | Low | Stub | Missing |
Esmirtazapine | 568 | Low | Stub | Missing |
Noradrenergic and specific serotonergic antidepressant | 671 | Mid | Start | Missing |
Rauwolscine | 572 | Low | Stub | Missing |